| Adriane Lynn Ebels, RPH | |
|
6840 Lake Michigan Dr, Allendale, MI 49401-8064 | |
| (616) 895-2200 | |
| Not Available |
| Full Name | Adriane Lynn Ebels |
|---|---|
| Gender | Female |
| Speciality | Pharmacist |
| Location | 6840 Lake Michigan Dr, Allendale, Michigan |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1346521895 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 5302028782 (Michigan) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Adriane Lynn Ebels, RPH 5089 Candlewood Ct, Coopersville, MI 49404-8712 Ph: () - | Adriane Lynn Ebels, RPH 6840 Lake Michigan Dr, Allendale, MI 49401-8064 Ph: (616) 895-2200 |
News Archive
A new study, presented today at the Society of NeuroInterventional Surgery's 15th Annual Meeting, found that new stroke imaging technology could decrease delays in care by up to 60 minutes, giving patients a better chance at making a full recovery.
The bacterium that causes Legionnaires' disease remains difficult to track. French researchers have now developed a new technique that should allow living representatives of this dangerous pathogen to be detected much more quickly than with conventional methods. As they report in the journal Angewandte Chemie, samples are exposed to an azide-modified compound that the pathogen specifically incorporates into its shell, which is made of saccharide units. A fluorescent marker attached to the azide groups is used to identify the pathogen.
In comparison to cystic fibrosis (CF) patients who regularly use inhaled corticosteroid, those who did not use these drugs for six months exhibited no positive or negative effects in terms of major disease factors.
Portola Pharmaceuticals has announced that it has initiated patient enrollment in INNOVATE-PCI, a large Phase II clinical trial of PRT060128, the Company's novel P2Y12 ADP receptor antagonist, in patients undergoing non-urgent percutaneous coronary intervention (PCI).
A first-of-its-kind study of safety issues surrounding the medical use of cannabis has just been launched. Known as the COMPASS study (Cannabis for the management of pain: assessment of safety study), the research initiative will follow 1400 chronic pain patients, 350 of whom use cannabis as part of their pain management strategy, for a one-year period.
› Verified 5 days ago
Jordan Kyle Seeger, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 6840 Lake Michigan Dr, Allendale, MI 49401 Phone: 616-895-2200 Fax: 616-895-2201 | |
Rex Heiser, R.PH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 6840 Lake Michigan Dr, Allendale, MI 49401 Phone: 616-895-2200 Fax: 616-895-2201 | |
William Paul Overkamp, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 6370 Lake Michigan Dr, Allendale, MI 49401 Phone: 616-895-7331 Fax: 866-365-7331 | |
Lisa Ann Sawicki, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 5296 Fillmore St, Allendale, MI 49401 Phone: 616-340-6882 | |
Steven Daly, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 6370 Lake Michigan Dr, Allendale, MI 49401 Phone: 616-895-7426 | |
John A Richardson, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 6370 Lake Michigan Dr, Allendale, MI 49401 Phone: 616-895-7426 Fax: 866-365-7331 |